Stanley Laman Group, Ltd. Dr Reddys Laboratories LTD Transaction History
Stanley Laman Group, Ltd.
- $529 Million
- Q1 2025
A detailed history of Stanley Laman Group, Ltd. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 140,000 shares of RDY stock, worth $1.94 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
140,000Holding current value
$1.94 Million% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding RDY
# of Institutions
264Shares Held
105MCall Options Held
71KPut Options Held
22.5K-
Morgan Stanley New York, NY11.3MShares$156 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.10.7MShares$149 Million0.28% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$139 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$131 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$77.8 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...